Progress in Psychiatry

New England Journal of Medicine

Volumn 329, Issue 8, 1993, Pages 552-560

  Michels, Robert ^a   Marzuk, Peter M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY NEUROSIS; DEPRESSION; DRUG DEPENDENCE; DYSTHYMIA; GENETIC LINKAGE; MAINTENANCE THERAPY; MENTAL DISEASE; NEUROPSYCHOLOGY; NEUROTRANSMISSION; OBSESSION; PATIENT CARE; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PRIORITY JOURNAL; PSYCHOTHERAPY; RELIABILITY; REVIEW; SCHIZOPHRENIA; UNITED STATES; GENETICS; HUMAN; PATHOPHYSIOLOGY; PREVALENCE; PSYCHIATRY; RESEARCH;

HUMAN; MENTAL DISORDERS; PREVALENCE; PSYCHIATRY; RESEARCH; SCHIZOPHRENIA; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027258089     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199308193290808     Document Type: Review

References (156)

1. Regier DA, Myers JK, Kramer M, The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984; 41: 934-941
2. Robins LN, Helzer JE, Weissman MM, Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949-958
3. Weissman MM, Leaf PJ, Bruce ML, Florio L The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry 1988; 145: 815-819
4. Karno M, Golding JM, Sorenson SB, Burnam MA The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988; 45: 1094-1099
5. Helzer JE, Robins LN, McEvoy L Post-traumatic stress disorder in the general population: findings of the Epidemiologic Catchment Area Survey. N Engl J Med 1987; 317: 1630-1634
6. Kulka RA, Schlenger WE, Fairbank JA, et al. The National Vietnam Veterans Readjustment Study: tables of findings and appendices. New York: Brunner/Mazel, 1990.
7. Christie KA, Burke JD Jr, Regier DA, Rae DS, Boyd JH, Locke BZ Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults. Am J Psychiatry 1988; 145: 971-975
8. Klerman GL, Weissman MM Increasing rates of depression. JAMA 1989; 261: 2229-2235
9. Regier DA, Goldberg ID, Taube CA The de facto US mental health services system: a public health perspective. Arch Gen Psychiatry 1978; 35: 685-693
10. Shapiro S, Skinner EA, Kessler LG, Utilization of health and mental health services: three Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1984; 41: 971-978
11. Jacob RG, Turner SM. Panic disorder: diagnosis and assessment. In: Frances AJ, Hales RE, eds. Review of Psychiatry. Vol. 7. Washington, D.C.: American Psychiatric Press, 1988:67-87.
12. Moore RD, Bone LR, Geller G, Mamon JA, Stokes EJ, Levine DM Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 1989; 261: 403-407
13. Perez-Stable EJ, Miranda J, Munoz RF, Ying YW Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990; 150: 1083-1088
14. Barrett JE, Barrett JA, Oxman TE, Gerber PD The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988; 45: 1100-1106
15. Wells KB, Stewart A, Hays RD, The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262: 914-919
16. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46: 984-992
17. Lee AS, Murray RM The long-term outcome of Maudsley depressives. Br J Psychiatry 1988; 153: 741-751
18. Kiloh LG, Andrews G, Neilson M The long-term outcome of depressive illness. Br J Psychiatry 1988; 153: 752-757
19. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A The Vermont longitudinal study of persons with severe mental illness. II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987; 144: 727-735
20. McGlashan TH A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 1988; 14: 515-542
21. Westermeyer JF, Harrow M. Course and outcome in schizophrenia. In: Tsuang MT, Simpson JC, eds. Handbook of schizophrenia. Vol. 3. Nosology, epidemiology and genetics of schizophrenia. Amsterdam: Elsevier, 1988:205-44.
22. Goldstein JM Gender differences in the course of schizophrenia. Am J Psychiatry 1988; 145: 684-689
23. Lin KM, Kleinman AM Psychopathology and clinical course of schizophrenia: a cross-cultural perspective. Schizophr Bull 1988; 14: 555-567
24. Vaillant GE. The natural history of alcoholism. Cambridge, Mass.: Harvard University Press, 1983.
25. Maser JD, Cloninger CR, eds. Comorbidity of mood and anxiety disorders. Washington, D.C.: American Psychiatric Press, 1990.
26. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983; 40: 620-625
27. Regier DA, Farmer ME, Rae DS, Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511-2518
28. Robins LN, Helzer JE, Weissman MM, Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949-958
29. Hesselbrock MN, Meyer RE, Keener JJ Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985; 42: 1050-1055
30. Grande TP, Wolf AW, Schubert DSP, Patterson MB, Brocco K Associations among alcoholism, drug abuse, and antisocial personality: a review of the literature. Psychol Rep 1984; 55: 455-474
31. Spiegel D Multiple personality as a post-traumatic stress disorder. Psychiatr Clin North Am 1984; 7: 101-110
32. Black DW, Warrack G, Winokur G Excess mortality among psychiatric patients: the Iowa Record-Linkage Study. JAMA 1985; 253: 58-61
33. Vital Statistics of the United States 1988. Vol. 2. Part A. Mortality. Washington, D.C.: Government Printing Office, 1991. (DHHS publication no. (PHS) 91-1101.)
34. Shaffer D The epidemiology of teen suicide: an examination of risk factors. J Clin Psychiatry 1988; 49: Suppl: 36-41
35. Murphy GE, Wetzel RD Suicide risk by birth cohort in the United States, 1949 to 1974. Arch Gen Psychiatry 1980; 37: 519-523
36. Rich CL, Young D, Fowler RC San Diego suicide study. I. Young vs old subjects. Arch Gen Psychiatry 1986; 43: 577-582
37. Boyd JH, Moscicki EK Firearms and youth suicide. Am J Public Health 1986; 76: 1240-1242
38. Phillips DP, Carstensen LL Clustering of teenage suicides after television news stories about suicide. N Engl J Med 1986; 315: 685-689
39. Gould MS, Shaffer D The impact of suicide in television movies: evidence of imitation. N Engl J Med 1986; 315: 690-694
40. Gould MS, Wallenstein S, Kleinman M Time-space clustering of teenage suicide. Am J Epidemiol 1990; 131: 71-78
41. Dorpat TL, Ripley HS The relationship between attempted suicide and committed suicide. Compr Psychiatry 1967; 8: 74-79
42. Barraclough B, Bunch J, Nelson B, Sainsbury P A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974; 125: 355-373
43. Marzuk PM, Tierney H, Tardiff K, Increased risk of suicide in persons with AIDS. JAMA 1988; 259: 1333-1337
44. McGlashan TH Borderline personality disorder and unipolar affective disorder: long-term effects of comorbidity. J Nerv Ment Dis 1987; 175: 467-473
45. Weissman MM, Klerman GL, Markowitz JS, Ouellette R Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989; 321: 1209-1214
46. Friedman S, Jones JC, Chernen L, Barlow DH Suicidal ideation and suicide attempts among patients with panic disorder: a survey of two outpatient clinics. Am J Psychiatry 1992; 149: 680-685
47. Beck AT, Steer RA, Sanderson WC, Skeie TM Panic disorder and suicidal ideation and behavior: discrepant findings in psychiatric outpatients. Am J Psychiatry 1991; 148: 1195-1199
48. Mann JJ, Stanley M, eds. Psychobiology of suicidal behavior. New York: New York Academy of Sciences, 1986.
49. Regier DA, Burke JD Jr. Quantitative and experimental methods in psychiatry. In: Kaplan HI, Sadock BJ, eds. Comprehensive textbook of psychiatry/V. 5th ed. Vol. 1. Baltimore: Williams & Wilkins, 1989:308-26.
50. Pauls DL, Leckman JF The inheritance of Gilles de La Tourette's syndrome and associated behaviors: evidence for autosomal dominant transmission. N Engl J Med 1986; 315: 993-997
51. Crowe RR, Noyes R, Pauls DL, Slymen D A family study of panic disorder. Arch Gen Psychiatry 1983; 40: 1065-1069
52. Fyer AJ, Mannuzza S, Gallops MS, Familial transmission of simple phobias and fears: a preliminary report. Arch Gen Psychiatry 1990; 47: 252-256
53. Ost L-G, Hugdahl K Acquisition of blood and dental phobia and anxiety response patterns in clinical patients. Behav Res Ther 1985; 23: 27-34
54. Crowe RR An adoption study of antisocial personality. Arch Gen Psychiatry 1974; 31: 785-791
55. Kendler KS, Gruenberg AM, Strauss JS An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 1981; 38: 982-984
56. Egeland JA, Gerhard DS, Pauls DL, Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 1987; 325: 783-787
57. Hodgkinson S, Sherrington R, Gurling H, Molecular genetic evidence for heterogeneity in manic depression. Nature 1987; 325: 805-806
58. p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature 1989; 342: 238-243
59. Baron M, Risch N, Hamburger R, Genetic linkage between X-chromosome markers and bipolar affective illness. Nature 1987; 326: 289-292
60. Baron M, Freimer NF, Risch N, Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nature Genet 1993; 3: 49-55
61. Goldin LR, Gershon ES Association and linkage studies of genetic marker loci in major psychiatric disorders. Psychiatr Dev 1983; 1: 387-418
62. Sherrington R, Brynjolfsson J, Petursson H, Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988; 336: 164-167
63. Detera-Wadleigh SD, Goldin LR, Sherrington R, Exclusion of linkage to 5q11-13 in families with schizophrenia and other psychiatric disorders. Nature 1989; 340: 391-393
64. Kennedy JL, Giuffra LA, Moises HW, Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 1988; 336: 167-170
65. Kaufmann CA, DeLisi LE, Lehner T, Gilliam TC Physical mapping, linkage analysis of a putative schizophrenia locus on chromosome 5q. Schizophr Bull 1989; 15: 441-452
66. St Clair D, Blackwood D, Muir W, No linkage of chromosome 5q11-q13 markers to schizophrenia in Scottish families. Nature 1989; 339: 305-309
67. Blum K, Noble EP, Sheridan PJ, Allelic association of human dopamine D receptor gene in alcoholism. JAMA 1990; 263: 2055-2060
68. Gelernter J, O'Malley S, Risch N, No association between an allele at the D dopamine receptor gene (DRD2) and alcoholism. JAMA 1991; 266: 1801-1807
69. Gershon ES, Merril CR, Goldin LR, DeLisi LE, Berrettini WH, Nurnberger JI Jr The role of molecular genetics in psychiatry. Biol Psychiatry 1987; 22: 1388-1405
70. Kendler KS. The feasibility of linkage studies in schizophrenia. In: Helmchen H, Henn FA, eds. Biological perspectives of schizophrenia. Vol. 40. New York: John Wiley, 1987:19-32.
71. Holzman PS, Solomon CM, Levin S, Waternaux CS Pursuit eye movement dysfunctions in schizophrenia: family evidence for specificity. Arch Gen Psychiatry 1984; 41: 136-139
72. Holzman PS, Kringlen E, Matthysse S, A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry 1988; 45: 641-647
73. Sitaram N, Dube S, Keshavan M, Davies A, Reynal P The association of supersensitive cholinergic REM-induction and affective illness within pedigrees. J Psychiatr Res 1987; 21: 487-497
74. Nurnberger JI Jr, Berrettini W, Tamarkin L, Hamovit J, Norton J, Gershon E Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder: a preliminary report. Neuropsychopharmacology 1988; 1: 217-223
75. Carroll BJ, Feinberg M, Greden JF, A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 1981; 38: 15-22
76. APA Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987; 144: 1253-1262
77. Berman KF, Weinberger DR. Functional localization in the brain in schizophrenia. In: Tasman A, Goldfinger SM, eds. Review of psychiatry. Vol. 10. Washington, D.C.: American Psychiatric Press, 1991:24-59.
78. Filipek PA, Kennedy DN, Caviness VS Jr, Rossnick SL, Spraggins TA, Starewicz PM Magnetic resonance imaging-based brain morphometry: development and application to normal subjects. Ann Neurol 1989; 25: 61-67
79. Masaryk TJ, Modic MT, Ross JS, Intracranial circulation: preliminary clinical results with three-dimensional (volume) MR angiography. Radiology 1989; 171: 793-799
80. Nelson JC, Mazure CM, Bowers MB Jr, Jatlow PI A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991; 48: 303-307
81. Di Costanzo E, Schifano F Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatr Scand 1991; 83: 456-459
82. Liebowitz MR, Schneier F, Campeas R, Phenelzine vs atenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 1992; 49: 290-300
83. Elkin I, Shea MT, Watkins JT, National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatment. Arch Gen Psychiatry 1989; 46: 971-982
84. Rosie JS Partial hospitalization: a review of the recent literature. Hosp Community Psychiatry 1987; 38: 1291-1299
85. Wilk RJ Implications of involuntary outpatient commitment for community health agencies. Am J Orthopsychiatry 1988; 58: 580-591
86. Hiday VA, Scheid-Cook TL A follow-up of chronic patients committed to outpatient treatment. Hosp Community Psychiatry 1989; 40: 52-59
87. Dorwart RA, Epstein SS Issues in psychiatric hospital care. Curr Opin Psychiatry 1991; 4: 789-793
88. Tischler GL Utilization management of mental health services by private third parties. Am J Psychiatry 1990; 147: 967-973
89. Dorwart RA Managed mental health care: myths and realities in the 1990s. Hosp Community Psychiatry 1990; 41: 1087-1091
90. Sharfstein SS Utilization management: managed or mangled psychiatric care? Am J Psychiatry 1990; 147: 965-966
91. Borland A, McRae J, Lycan C Outcomes of the five years of continuous intensive case management. Hosp Community Psychiatry 1989; 40: 369-376
92. Stroul BA Residential crisis services: a review. Hosp Community Psychiatry 1988; 39: 1095-1099
93. Creed F, Black D, Anthony P Day-hospital and community treatment for acute psychiatric illness: a critical appraisal. Br J Psychiatry 1989; 154: 300-310
94. Anderson CM, Hogarty GE, Reiss DJ Family treatment of adult schizophrenic patients: a psycho-educational approach. Schizophr Bull 1980; 6: 490-505
95. Keefe RSE, Mohs RC, Losonczy MF, Characteristics of very poor outcome schizophrenia. Am J Psychiatry 1987; 144: 889-895
96. Kendler KS, Gruenberg AM, Tsuang MT A family study of the subtypes of schizophrenia. Am J Psychiatry 1988; 145: 57-62
97. Baron M, Risch N The spectrum concept of schizophrenia: evidence for a genetic-environmental continuum. J Psychiatr Res 1987; 21: 257-267
98. Crow TJ Molecular pathology of schizophrenia: more than one disease process? BMJ 1980; 280: 66-68
99. Carpenter WT Jr, Heinrichs DW, Wagman AM Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145: 578-583
100. Andreasen NC, Olsen S Negative v positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982; 39: 789-794
101. Goldberg TE, Gold JM, Braff DL. Neuropsychological functioning and time-linked information processing in schizophrenia. In: Tasman A, Goldfinger SM, eds. Review of psychiatry. Vol. 10. Washington, D.C.: American Psychiatric Press, 1991:60-78.
102. Goldberg TE, Ragland D, Torrey EF, Gold JM, Bigelow LB, Weinberger DR Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1990; 47: 1066-1072
103. Miyauchi T, Tanaka K, Hagimoto H, Miura T, Kishimoto H, Matsushita M Computerized EEG in schizophrenic patients. Biol Psychiatry 1990; 28: 488-494
104. Lindstrom LH, Wieselgren IM, Klockhoff I, Svedberg A Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients. Biol Psychiatry 1990; 28: 435-442
105. Braff DL, Geyer MA, Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 1990; 47: 181-188
106. Holzman PS Eye movement dysfunctions and psychosis. Int Rev Neurobiol 1985; 27: 179-205
107. Meltzer HY The neurobiology of schizophrenia. Curr Opin Psychiatry 1991; 4: 90-95
108. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990; 322: 789-794
109. Brown R, Colter N, Corsellis JAN, Postmortem evidence of structural brain changes in schizophrenia: differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry 1986; 43: 36-42
110. Shenton ME, Kikinis R, Jolesz FA, Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992; 327: 604-612
111. Illowsky BP, Juliano DM, Bigelow LB, Weinberger DR Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurol Neurosurg Psychiatry 1988; 51: 209-213
112. Jeste DV, Lohr JB Hippocampal pathological findings in schizophrenia: a morphometric study. Arch Gen Psychiatry 1989; 46: 1019-1024
113. Weinberger DR, Berman KF, Illowsky BP Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 1988; 45: 609-615
114. Berman KF, Illowsky BP, Weinberger DR Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. Arch Gen Psychiatry 1988; 45: 616-622
115. Lyon M, Barr CE, Cannon TD, Mednick SA, Shore D Fetal neural development and schizophrenia. Schizophr Bull 1989; 15: 149-161
116. McNeil TF. Obstetric factors and perinatal injuries. In: Tsuang MT, Simpson JC, eds. Handbook of schizophrenia. Vol. 3. Nosology, epidemiology and genetics of schizophrenia. Amsterdam: Elsevier, 1988:319-44.
117. Conrad AJ, Scheibel AB Schizophrenia and the hippocampus: the embryological hypothesis extended. Schizophr Bull 1987; 13: 577-587
118. Pert CB, Knight JG, Laing P, Markwell MAK Scenarios for a viral etiology of schizophrenia. Schizophr Bull 1988; 14: 243-247
119. Mednick SA, Machon RA, Huttunen MO, Bonett D Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988; 45: 189-192
120. Nasrallah HA, Wilcox JA Gender differences in the etiology and symptoms of schizophrenia: genetic vs brain injury factors. Ann Clin Psychiatry 1989; 1: 51-53
121. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G Positron emission tomographic analysis of central D and D dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992; 49: 538-544
122. Hyde TH, Casanova MF, Kleinman JE, Weinberger DR. Neuroanatomical and neurochemical pathology in schizophrenia: In: Tasman A, Goldfinger SM, eds. Review of psychiatry. Vol. 10. Washington, D.C.: American Psychiatric Press, 1991:7-23.
123. Bleich A, Brown SL, Kahn R, van Praag HM The role of serotonin in schizophrenia. Schizophr Bull 1988; 14: 297-315
124. Arana GW, Hyman SE. Handbook of psychiatric drug therapy. 2nd ed. Boston: Little, Brown, 1991:4-37.
125. Pickar D, Litman RE, Konicki PE, et al. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia. In: Andreasen NC, ed. Modern problems of pharmacopsychiatry. Schizophrenia: positive and negative symptoms and syndromes. Vol. 24. Basel: Karger, 1990:124-51.
126. Pickar D Perspectives on a time-dependent model of neuroleptic action. Schizophr Bull 1988; 14: 255-268
127. Volavka J, Cooper T, Czobor P, Haloperidol blood levels and clinical effects. Arch Gen Psychiatry 1992; 49: 354-361
128. Marder SR, Van Putten T, Mintz J, Lebell M, McKenzie J, May PRA Low- and conventional-dose maintenance therapy with fluphenazine decanoate: two year outcome. Arch Gen Psychiatry 1987; 44: 518-521
129. Baldessarini RJ, Cohen BM, Teicher MH Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 1988; 45: 79-91
130. Wolkowitz OM, Breier A, Doran A, Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: preliminary results. Arch Gen Psychiatry 1988; 45: 664-671
131. Lerner Y, Mintzer Y, Schestatzky M Lithium combined with haloperidol in schizophrenic patients. Br J Psychiatry 1988; 153: 359-362
132. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB Adjunctive imipramine in the treatment of postpsychotic depression: a controlled trial. Arch Gen Psychiatry 1987; 44: 533-539
133. Okuma T, Yamashita I, Takahashi R, A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiatr Scand 1989; 80: 250-259
134. Carpenter WT Jr, Heinrichs DW, Hanlon TE A comparative trial of pharmacologic strategies in schizophrenia. Am J Psychiatry 1987; 144: 1466-1470
135. Jolley AG, Hirsch SR, McRink A, Manchanda R Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year. BMJ 1989; 298: 985-990
136. Brown GW, Carstairs GM, Topping G Post-hospital adjustment of chronic mental patients. Lancet 1958; 2: 685-689
137. Falloon IRH, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med 1982; 306: 1437-1440
138. Hogarty GE, McEvoy JP, Munetz M, Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia: results of a two-year controlled study. Arch Gen Psychiatry 1988; 45: 797-805
139. Rifkin A, Siris S. Drug treatment of acute schizophrenia: In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1095-101.
140. Fleischhacker WW, Roth SD, Kane JM The pharmacologic treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol 1990; 10: 12-21
141. Adler LA, Angrist B, Reiter S, Rotrosen J Neuroleptic-induced akathisia: a review. Psychopharmacology 1989; 97: 1-11
142. Gardos G, Cole JO, Salomon M, Schniebolk S Clinical forms of severe tardive dyskinesia. Am J Psychiatry 1987; 144: 895-902
143. Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P The natural history of tardive dyskinesia. J Clin Psychopharmacol 1988; 8: Suppl: 31S-37S
144. Fornazzari X, Grossman H, Thornton J, Seeman MV Tardive dyskinesia: a five year follow-up. Can J Psychiatry 1989; 34: 700-703
145. Lieberman JA, Saltz BL, Johns CA, Pollack S, Kane JM Clozapine effects on tardive dyskinesia. Psychopharmacol Bull 1989; 25: 57-62
146. Kane JM, Honigfeld G, Singer J, Meltzer H Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull 1988; 24: 62-67
147. Marder SR, Van Putten T Who should receive clozapine? Arch Gen Psychiatry 1988; 45: 865-867
148. Hyttel J, Larsen J-J, Christensen AV, Arnt J. Receptor-binding profiles of neuroleptics. In: Casey DE, Chase TN, Christensen AV, Gerlach J, eds. Dyskinesia: research and treatment. Berlin, Germany: Springer-Verlag, 1985:9-18.
149. Peroutka SJ, Synder SH Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980; 137: 1518-1522
150. Pickar D, Owen RR, Litman RE, Konicki PE, Gutierrez R, Rapaport MH Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 1992; 49: 345-353
151. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J A prospective study of clozapine in treatment-resistant schizophrenic patients. 1. Preliminary report. Psychopharmacology (Berl) 1989; 99: Suppl: S68-S72
152. Krupp P, Barnes P Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology (Berl) 1989; 99: Suppl: S118-S121
153. Petit M, Zann M, Lesieur P, Colonna L The effect of sulpiride on negative symptoms of schizophrenia. Br J Psychiatry 1987; 150: 270-271
154. Farde L, Wiesel FA, Jansson P, Uppfeldt G, Wahlen A, Sedvall G An open label trial of raclopride in acute schizophrenia: confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology (Berl) 1988; 94: 1-7
155. den Boer JA, Verhoeven WMA, Westenberg HGM Remoxipride, a novel atypical neuroleptic, in the treatment of schizophrenia. Psychopharmacol Bull 1987; 23: 206-210
156. 2 receptor blockers in schizophrenia. Clin Neuropharmacol 1991; 13: Suppl 2: 182-183